Novo Nordisk A/S (NVO)

39.51 -7.91 (-16.68%) USD  |  NYSE  |  Feb 23, 15:17
More

Novo Nordisk Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for NVO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Ascendis Pharma A/S Upgrade
Evaxion AS Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade
DBV Technologies SA Upgrade